USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$105.57M
Market Cap
-
P/E Ratio
-0.64
EPS
$3.16
52 Week High
$1.32
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$823K |
Total Revenue | $103K |
Cost Of Revenue | $926K |
Costof Goods And Services Sold | $926K |
Operating Income | -$36M |
Selling General And Administrative | $7.3M |
Research And Development | $29M |
Operating Expenses | $36M |
Investment Income Net | - |
Net Interest Income | $2.9M |
Interest Income | $3.8M |
Interest Expense | $852K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $926K |
Income Before Tax | -$33M |
Income Tax Expense | -$18K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$33M |
Comprehensive Income Net Of Tax | - |
Ebit | -$33M |
Ebitda | -$32M |
Net Income | -$33M |
Field | Value (USD) |
---|---|
Total Assets | $89M |
Total Current Assets | $88M |
Cash And Cash Equivalents At Carrying Value | $85M |
Cash And Short Term Investments | $85M |
Inventory | - |
Current Net Receivables | $8.3K |
Total Non Current Assets | $1.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.6M |
Other Non Current Assets | - |
Total Liabilities | $39M |
Total Current Liabilities | $38M |
Current Accounts Payable | $4.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $18M |
Total Non Current Liabilities | $560K |
Capital Lease Obligations | $284K |
Long Term Debt | $417K |
Current Long Term Debt | $18M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $18M |
Other Current Liabilities | $16M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $51M |
Treasury Stock | - |
Retained Earnings | -$311M |
Common Stock | $5.9K |
Common Stock Shares Outstanding | $36M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$30M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $926K |
Capital Expenditures | $34K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $1.1M |
Cashflow From Financing | $3.8M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$33M |
Field | Value (USD) |
---|---|
Gross Profit | -$823K |
Total Revenue | $103K |
Cost Of Revenue | $926K |
Costof Goods And Services Sold | $926K |
Operating Income | -$36M |
Selling General And Administrative | $7.3M |
Research And Development | $29M |
Operating Expenses | $36M |
Investment Income Net | - |
Net Interest Income | $2.9M |
Interest Income | $3.8M |
Interest Expense | $852K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $926K |
Income Before Tax | -$33M |
Income Tax Expense | -$18K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$33M |
Comprehensive Income Net Of Tax | - |
Ebit | -$33M |
Ebitda | -$32M |
Net Income | -$33M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China.